Azienda Ospedaliera Santa Maria

Terni 5100

0 studies enrolling now · 2 studies all time

What they study most

Follicular Lymphoma (FL), Marginal Zone Lymphoma, Multiple Myeloma, Non Hodgkin Lymphoma

Studies at this site

• Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab — Stopped early
• Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early